These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32412788)

  • 1. β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.
    Manglik A; Wingler LM; Rockman HA; Lefkowitz RJ
    Circulation; 2020 Jul; 142(4):318-320. PubMed ID: 32412788
    [No Abstract]   [Full Text] [Related]  

  • 2. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    Ruiz de Pellón Santamaría Á
    J Clin Psychopharmacol; 2020; 40(6):641-642. PubMed ID: 33136928
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19: A Defining Moment for Clinical Pharmacology?
    van der Graaf PH; Giacomini KM
    Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential Unconventional Medicines for the Treatment of SARS-CoV-2.
    Coppola M; Mondola R
    Drug Res (Stuttg); 2020 Jun; 70(6):286. PubMed ID: 32428941
    [No Abstract]   [Full Text] [Related]  

  • 6. Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis.
    Tong TRS
    Infect Disord Drug Targets; 2020; 20(3):351. PubMed ID: 32696730
    [No Abstract]   [Full Text] [Related]  

  • 7. Can an Old Ally Defeat a New Enemy?
    Gurbel PA; Bliden KP; Schrör K
    Circulation; 2020 Jul; 142(4):315-317. PubMed ID: 32478567
    [No Abstract]   [Full Text] [Related]  

  • 8. Cationic drugs and COVID-19.
    Brenna OV; Torretta S; Pignataro L; Di Berardino F
    Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
    Ayaz S; Crea F
    Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
    [No Abstract]   [Full Text] [Related]  

  • 10. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 11. Teaching Old Drugs New Tricks: Statins for COVID-19?
    Fajgenbaum DC; Rader DJ
    Cell Metab; 2020 Aug; 32(2):145-147. PubMed ID: 32755604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
    Marouf BH; Dizaye K
    Drug Discov Ther; 2020; 14(3):109-116. PubMed ID: 32669519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy regarding ACE inhibitors / ARBs in COVID-19.
    Soria Arcos F; Romero Puche A; Vicente Vera T
    Rev Esp Cardiol (Engl Ed); 2020 Jun; 73(6):516. PubMed ID: 32371022
    [No Abstract]   [Full Text] [Related]  

  • 14. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
    Ackerman EE; Shoemaker JE
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations.
    Celik O; Celik N; Aydin S; Baysal B; Aydin S; Saglam A; Gursu Y; Dalkilic S; Ulas M; Ozcil MD; Tayyar AT; Cengiz F; Ugur K; Akkoc RF; Ersahin AA
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):221-229. PubMed ID: 32538775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
    Pang X; Cui Y; Zhu Y
    Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
    [No Abstract]   [Full Text] [Related]  

  • 18. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
    Sever P; Johnston SL
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
    [No Abstract]   [Full Text] [Related]  

  • 19. Boosting the arsenal against COVID-19 through computational drug repurposing.
    Ciliberto G; Cardone L
    Drug Discov Today; 2020 Jun; 25(6):946-948. PubMed ID: 32304645
    [No Abstract]   [Full Text] [Related]  

  • 20. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
    Ghahestani SM; Mahmoudi J; Hajebrahimi S; Sioofy-Khojine AB; Salehi-Pourmehr H; Sadeghi-Ghyassi F; Mostafaei H
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):13-17. PubMed ID: 32534506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.